TATAA Biocenter Expands Its Next-Generation Sequencing Offerings with HTG Molecular Diagnostics’ Unique HTG EdgeSeq System
HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel
HTG Molecular Diagnostics and Oncologie Complete Master Agreement to Partner on Biomarker Development for Immuno-oncology Drug Development
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
Medical Device Investing HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock
HTG Molecular Diagnostics Announces Distribution Agreements with Gamidor in Israel and Durviz in Spain and Portugal
